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Objective
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all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pone.0231891

The SI gene encodes the sucrase-isomaltase enzyme, a disaccharidase expressed in the
intestinal brush border. Hypomorphic SI variants cause recessive congenital sucrase-isomaltase deficiency (CSID) and related gastrointestinal (GI) symptoms. Among children presenting with chronic, idiopathic loose stools, we assessed the prevalence of CSIDassociated SI variants relative to the general population and the relative GI symptom burden
associated with SI genotype within the study population.

Copyright: © 2020 Chumpitazi et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.

Methods
A prospective study conducted at 18 centers enrolled 308 non-Hispanic white children �18
years old who were experiencing chronic, idiopathic, loose stools at least once per week for
>4 weeks. Data on demographics, GI symptoms, and genotyping for 37 SI hypomorphic variants were collected. Race/ethnicity-matched SI data from the Exome Aggregation Consortium (ExAC) database was used as the general population reference.
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Results
Compared with the general population, the cumulative prevalence of hypomorphic SI variants was significantly higher in the study population (4.5% vs. 1.3%, P < .01; OR = 3.5 [95%
CI: 6.1, 2.0]). Within the study population, children with a hypomorphic SI variant had a
more severe GI symptom burden than those without, including: more frequent episodes of
loose stools (P < .01), higher overall stool frequency (P < .01), looser stool form (P = .01)
and increased flatulence (P = .02).

Conclusion
Non-Hispanic white children with chronic idiopathic loose stools have a higher prevalence of
CSID-associated hypomorphic SI variants than the general population. The GI symptom
burden was greater among the study subjects with a hypomorphic SI variant than those
without hypomorphic SI variants.

Introduction
A large number of children around the world experience chronic gastrointestinal (GI) symptoms diagnosed as functional (nonorganic) GI disorders [1]. Functional GI disorders may
have several contributing pathophysiologic factors, including carbohydrate malabsorption [2].
The sucrase-isomaltase enzyme, encoded by the SI gene, is a predominant member of the
disaccharidases responsible for the digestion of dietary carbohydrates in humans [3]. Hypomorphic SI gene variants reduce enzyme activity, resulting in congenital sucrase-isomaltase
deficiency (CSID) and characteristic GI symptoms. To date, 37 SI variants have been identified
in diagnosed CSID patients and found to be hypomorphic [4–12]. Patients with CSID experience sucrose malabsorption, leading to colonic osmosis and fermentation, and subsequent
osmotic diarrhea and excessive flatulence [4, 13]. Heterozygotes of hypomorphic SI variants
may also experience GI symptoms. Small case reports have associated hypomorphic SI heterozygosity with decreased intestinal sucrase enzymatic activity and characteristic GI symptoms
[3, 12, 14]. In two recent studies, the prevalence of heterozygous carriers of hypomorphic SI
variants was small but significantly greater among adults diagnosed with irritable bowel syndrome (IBS) than in controls, suggestive of an increased IBS susceptibility [15, 16].
A subset of children with functional GI disorders has frequent diarrhea. Currently, the
potential contribution of hypomorphic SI variants in these children is unknown. Therefore,
we had two primary study objectives. The first study objective was to determine the relative
prevalence of hypomorphic SI variants among children with chronic, idiopathic, loose stools
versus the general population. The second study objective in children with chronic, idiopathic,
loose stools was to determine the potential impact of hypomorphic SI variants on symptom
burden.

Methods
Study design and subjects
A prospective, 18-center study conducted in the United States enrolled subjects �18 years old
who presented at a pediatric gastroenterology center with loose stools at least once per week
for a minimum of 4 weeks.
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The study objectives were i) to determine the prevalence of hypomorphic SI variants within
the study population versus a genetic database for the general population, and ii) to determine
the symptom burden among the study subjects with hypomorphic SI variants versus study
subjects without hypomorphic SI variants.
Exclusion criteria included: identification of any condition(s) or finding(s) that, in the
opinion of the investigator, suggested an organic etiology for the subject’s GI symptoms;
abdominal pain primarily related to constipation; suspected GI infectious disease or other
infectious diseases; known GI disease (eg, celiac disease); a history of antibiotic therapy or viral
gastroenteritis within the previous 2 weeks; known hepatitis B or C infection or chronic liver
disease; cancer or systemic infections; severe neurologic impairment (preventing reporting of
symptoms); planned or previous abdominal surgery (eg, bowel resection); severe, uncontrolled
systemic diseases; or current use of sacrosidase, an enzyme replacement therapy for CSID.
The pediatric gastroenterology centers in this study were comprised of private practices
and academic centers. Each investigator was asked to follow his or her standard clinical practice to ensure an organic etiology was not present. Evaluations took place during a clinic visit.
All participating centers received approval from their local institutional review boards (IRB).
The institutional review boards included: Baylor College of Medicine IRB, Children’s Hospital
Los Angeles Committee on Clinical Investigators, Nationwide Children’s Hospital IRB, Children’s Mercy Hospital Pediatric IRB, Johns Hopkins IRB, The Children’s Hospital of Philadelphia Research Institute IRB, The Arnold Palmer Medical Center IRB, The Duke University
Health System IRB, Massachusetts General Hospital IRB, Children’s Hospital of Wisconsin
IRB, Colorado Multiple IRB, The Indiana University IRB, Children’s Healthcare of Atlanta
IRB, The University of Utah IRB, Children’s Hospital & Research Center Oakland IRB, University of Mississippi Medical Center IRB, Columbia University Medical Center IRB, and Sutter Health IRB. All subjects provided assent with a legal guardian providing written informed
consent. The study was conducted from May 2013 to July 2015. All authors had access to the
study data and approved the final manuscript.

Genotyping
Four buccal swabs were obtained for DNA extraction; genotyping of the 37 known CSID-associated variants (S1 Table) was completed by a validated capillary electrophoresis assay (SNaPshot; Laboratory Corporation of America, Research Triangle Park, NC). Intra-assay
reproducibility was assessed on 12-sample runs in 3 separate, replicate assays, with samples
representing the 37 known hypomorphic variants of the SI gene associated with CSID. The
reported prevalence of CSID-associated variants included subjects with simple heterozygous,
compound heterozygous, and homozygous SI variant genotypes. Subjects without hypomorphic SI variants did not have any of the 37 analyzed CSID-associated variants on either
allele.
The reference for the cumulative prevalence of hypomorphic SI variants in the general population was obtained from the Exome Aggregation Consortium (ExAC) database [15]. As the
ExAC database data has now been incorporated into the gnomAD project, the evaluated ExAC
data is currently available via a legacy link (https://console.cloud.google.com/storage/browser/
gnomad-public/legacy). For this study, SI sequencing data for 32,550 unrelated non-Hispanic
white individuals was retrieved from the ExAC database. The ExAC database provides publicly
available genetic data from thousands of unrelated individuals of various races/ethnicities,
from aggregated disease-specific and population genetic studies. The ExAC database has been
used as a control for genetic studies evaluating a wide range of GI disorders, including adult
IBS [15–18].
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Symptom assessment
Subjects were asked to complete a demographic and symptom questionnaire to capture gender, age, race/ethnicity, and episodes of GI symptoms. All GI symptoms (abdominal pain, diarrhea, excessive flatus) were assessed using a study-specific questionnaire, including frequency,
duration, and severity of bowel complaints (S2 Table). The GI symptom burden of the ExAC
reference population is unknown.
Stool form was assessed using the modified Bristol Stool Form Scale (BSFS; categories 1–5)
for children, with higher scores corresponding to looser stools [19]. The symptom questionnaire was generally given to children aged >7 years, with a parent otherwise providing
answers.

Statistical analyses
Results are presented using descriptive statistics, including mean ± standard deviation for continuous data and prevalence and/or percentages for categorical data. The cumulative prevalence of hypomorphic SI variants in this study population was compared with a race/ethnicitymatched ExAC prevalence using the Pearson’s chi-squared test. Reported P-values are onetailed, and P < .05 was considered statistically significant. Increased risk was estimated using
the odds ratio (OR) with a 95% confidence interval (CI).

Results
Population characteristics
Three hundred and eight non-Hispanic white children with chronic, idiopathic, loose stools
were enrolled and assessed. There was a slight predominance of boys (58%). Diarrhea, defined
as chronic loose stools, was identified as the primary GI symptom.

Prevalence of hypomorphic SI variants
Among the 308 subjects, 14 had at least 1 hypomorphic SI variant, for a prevalence of 4.5%.
Study subjects had a statistically significantly higher prevalence of hypomorphic SI variants
than the race/ethnicity-matched general population (4.5% vs. 1.3%, P < .01; OR = 3.5; 95% CI:
6.1, 2.0) (Table 1).
Thirteen of the 14 subjects with an identified hypomorphic SI variant were simple heterozygous genotypes (93%), and one subject had a compound heterozygous genotype. Five distinct
hypomorphic SI variants were identified among these 14 study subjects; 4 of these 5 distinct
hypomorphic SI variants are the most common SI variants found in patients diagnosed with
CSID (G1073D, V577G, R1124x and F1745C; Table 2) [12]. There were no statistically significant differences between the prevalence of hypomorphic SI variants in male and female subjects (4.5% and 4.7%, respectively).

Symptom burden associated with hypomorphic SI variants
Mean differences in the symptom burden of subjects with a hypomorphic SI variant versus
subjects without a hypomorphic SI variant are reported in Table 3. Compared with the 294
subjects without a hypomorphic SI variant, the 14 with a hypomorphic SI variant had significantly more frequent GI symptoms, including: more frequent weekly episodes of loose stools
(P < .01), higher daily overall stool frequency (P < .01), looser stool form (P = .01) and
increased flatulence (P = .02). Subjects with a hypomorphic SI variant also were younger (P <
.01).
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Table 1. Relative prevalence of hypomorphic SI variants.
Study Population

ExAC Population

Number

Prevalence

Number

Prevalence

Wild-type SI

294

95.5%

32,116

98.7%

Hypomorphic SI varianta

14

4.5%

434

1.3%

Total

308

32,550

95% CI
P-Value

< .01

OR

Upper

Lower

3.5

6.1

2.1

a

Includes one compound heterozygote in the study population.

https://doi.org/10.1371/journal.pone.0231891.t001

Discussion
We found hypomorphic SI variants among a study population of non-Hispanic white children
with chronic, idiopathic, loose stools. The prevalence of these known hypomorphic SI variants
was significantly higher in this study population compared to a race/ethnicity-matched general
population. In addition, study subjects with a hypomorphic SI variant had a greater GI symptom burden than study subjects without hypomorphic SI variants. These findings add to the
growing evidence suggesting heterozygous SI hypomorphic variants are associated with the
development of CSID-associated GI symptoms.
The most common hypomorphic SI variants in our study cohort were also the hypomorphic
SI variants most commonly identified in other genetic studies of individuals diagnosed with
CSID [12]. Although the biochemical and functional effects of several SI variants have been well
characterized and found to diminish sucrase and isomaltase function [4, 5, 8], the potential
effect of a heterozygous genotype of a hypomorphic SI variant is still being studied and remains
to be fully elucidated. Using either the duodenal disaccharidase enzyme assay or the 13C breath
test to determine the extent of sucrase enzyme activity, family members of patients with CSID
(with either presumed or well-documented heterozygosity for a hypomorphic SI variant) have
been found to have decreased sucrase enzyme activity [14, 20]. Further supporting the potential
pathobiological effect of heterozygous genotypes of hypomorphic SI variants are recent findings
by Henström et al and Garcia-Etxebarria et al, who reported that heterozygous SI gene variants
may be associated with an increased risk for diagnosis of adult IBS [15, 16]. Nevertheless, further prospective clinical evaluations including identification of heterozygous hypomorphic SI
variants, functional measurements of sucrase-isomaltase (e.g., enzyme assays), controlled dietary exposures, and basic cellular and molecular based studies are needed to more clearly determine the role of hypomorphic SI heterozygous genotypes.
Table 2. Hypomorphic SI variants identified in the study population.
Rs

Grantham Scorea

Subjects (N = 308)

b

121912616

94

7

b,c

121912615

109

5c

b

F1745C

79717168

205

1

R1124xb

N/A

N/A

1

I1378Sc

148831941

142

1c

SI Variants
G1073D
V577G

Total Unique Subjects

14c

a

Grantham score is a measure of evolutionary distance in amino acid substitutions, classified by increasing chemical dissimilarity. A higher score reflects a higher

likelihood that a substitution will be deleterious based on four general rankings: conservative (0–50), moderately conservative (51–100), moderately radical (101–150),
or radical (�151)
One of the four most common CSID variations

b
c

One participant was a compound heterozygote with both a V577G and an I1378S variant.

https://doi.org/10.1371/journal.pone.0231891.t002
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Table 3. Symptom burden of study subjects by SI genotype.
Total study population

With Hypo-morphic SI Variant

Without Hypo-morphic SI Variants

Study subjects

308

14

294

Age (mean yr)

7.6

3.8

7.7

4.0

Symptom duration (mo)

8.8

8.6

8.9

0.3

NS

Diarrhea episode (d/wk)

5.1

6.6

5.0

1.6

< .01

Stools (#/d)

3.4

5.3

3.3

1.9

< .01

Pediatric BSFS, last diarrheal event

4.3

4.7

4.3

0.4

.01

2Abdominal pain (d/wk)

3.6

3.6

3.6

——

NS

Pain events (#/d)

1.4

1.4

1.4

——

NS

Pain severity (6-point VAS)

2.4

2.4

2.4

——

NS

Gas (d/wk)

4.9

6.3

4.9

1.4

.02

Gas events (#/d)

1.9

2.1

1.9

0.3

NS

Mean Difference P-value
< .01

Symptom Burden (mean)

BSFS, modified Bristol Stool Form Scale for children (categories 1–5, higher scores corresponding to looser stools); NS, not statistically significant; VAS, visual analog
scale, 0–5
https://doi.org/10.1371/journal.pone.0231891.t003

Identifying the underlying factors contributing to functional GI symptoms is important as
this knowledge may lead to more effective therapies. Children with CSID have been shown to
benefit from a sucrose-restricted diet and enzyme replacement therapy with sacrosidase taken
with meals [21–24]. Gastrointestinal symptoms related to diminished sucrase-isomaltase activity are primarily correlated with factors such as the extent of functional intestinal enzyme
activity present and the amount of sucrose and/or starch ingested [4, 13]. It should be noted
that in one study, a child with a heterozygous genotype of a hypomorphic SI variant, who was
a sibling of a CSID-diagnosed subject, was asymptomatic [10]. Future studies in this area may
consider assessing both enzyme activity and dietary intake relative to SI hypomorphic variants
and the associated GI symptom burden.
There are a few limitations to this study. One limitation is that the age-, gender-, and race/
ethnicity-matched control population was not actively recruited. However, even though the GI
symptoms associated with the database entries are unknown, the ExAC reference database of a
significantly large population allowed for a race/ethnicity-matched comparison. Second, the
entire SI gene was not sequenced in participants. This opens the possibility–however unlikely–
that some of the study subjects identified as lacking a hypomorphic SI variant had one or more
hypomorphic SI variants in an uninvestigated portion of the SI gene. In addition, some of the
study subjects identified as having a simple heterozygous genotype of a hypomorphic SI variant may also have a hypomorphic SI variant in an uninvestigated portion of the SI gene.
There are several strengths in the study. First, this multicenter effort was, to our knowledge,
the largest of its kind in children with functional GI symptoms. Second, SI genotyping focused
on 37 CSID-associated SI variants that have been well characterized biochemically as hypomorphic in prior studies. This leads to greater plausibility of the results. Third, the study was
conducted in various academic and private practice settings, which will lead to greater generalizability of our findings.

Conclusion
In conclusion, we found CSID-associated hypomorphic SI variants in a study population of
non-Hispanic white children with chronic, idopathic, loose stools. These CSID-associated
hypomorphic SI variants were found to occur at a significantly higher prevalence than that
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reported in a race/ethnicity-matched reference population. Subjects with hypomorphic SI variants had more GI symptoms of frequent diarrhea and gas, a higher stool frequency, and looser
stools compared to those in the study population without hypomorphic SI variants.

Supporting information
S1 Table. Hypomorphic SI Variants Identified in children with chronic gastrointestinal symptoms. Ala, alanine; Arg, arginine; Asp, aspartate; Cys, cysteine; Gln, glutamine; Glu, glutamate;
Gly, glycine; I, isomaltase; Ile, isoleucine; Leu, leucine; N/A, not available; Phe, phenylalanine Pro,
proline; S, sucrase; Ser, serine; Thr, threonine; Tyr, tyrosine; Trp, tryptophan; Val, valine.
(DOCX)
S2 Table. Study questionnaire.
(DOCX)
S1 Data.
(XLSX)
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Keiser M, Alfalah M, Pröpsting MJ, Castelletti D, Naim HY. Altered folding, turnover, and polarized sorting act in concert to define a novel pathomechanism of congenital sucrase-isomaltase deficiency. J Biol
Chem. 2006; 281(20):14393–9. https://doi.org/10.1074/jbc.M513631200 PMID: 16543230

9.

Ritz V, Alfalah M, Zimmer KP, Schmitz J, Jacob R, Naim HY. Congenital sucrase-isomaltase deficiency
because of an accumulation of the mutant enzyme in the endoplasmic reticulum. Gastroenterology.
2003; 125(6):1678–85. https://doi.org/10.1053/j.gastro.2003.09.022 PMID: 14724820

10.

Sander P, Alfalah M, Keiser M, Korponay-Szabo I, Kovács JB, Leeb T, et al. Novel mutations in the
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